Former CEO Pleads Guilty to Marketing Migraine Treatment Device Without FDA’s Authorization

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Former CEO Pleads Guilty to Marketing Migraine Treatment Device Without FDA’s Authorization

Dennis Tosh

October 16, 2023 at 02:06 PM EST

The former CEO of a medical device company in Utah has pleaded guilty to two misdemeanor charges stemming from the firm’s marketing of a catheter intended to treat migraine headaches. The company had not obtained premarket approval or clearance for the product from the FDA (United States v. Wright, No. 2:23-cr-00276-CMR (D. Utah)). A misdemeanor information filed July 25 in t... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Former CEO Pleads Guilty to Marketing Migraine Treatment Device Without FDA’s Authorization

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT